Federal Regulation
Get the latest news and insights on regulatory developments affecting financial advisors and the stock market and trading, including news about the SEC, DOL, IRS and the Financial Industry Regulatory Authority.
Providers of 403(b) Plans Gear Up for Regulatory Challenges
By Melanie WaddellProviders of 403(b) plans that are subject to ERISA will face regulatory challenges this yearnamely complying with the Department of Labors fee disclosure rule as well as the expanded Form 5500 reporting requirements.
January 09, 2012
The Costs of FINRA Oversight of RIAs: Running the SRO NumbersAt last, credible information on the costs of having an SROor notto oversee advisors, and what each scenario would cost RIAs in dollars and cents.
January 07, 2012
SEC Redefines Insurance Suitability Qualifiers for Certain ProductsThe SEC recently redefined the accredited investor standard that is used to determine whether insureds are permitted to purchase exotic insurance products.
January 06, 2012
U.S. IRS Audited Record Millionaires in Fiscal ’11 (Bloomberg)2011 marked the third consecutive year that the IRS increased its audit rate on individual tax returns showing income of more than $1 million.
January 06, 2012
U.S. IRS Audited Record Millionaires in Fiscal ’11 (Bloomberg)2011 marked the third consecutive year that the IRS increased its audit rate on individual tax returns showing income of more than $1 million.
January 06, 2012
IRS Puts W-2 Health Advice in a NutshellEmployers can keep HSAs and LTCI out; transitional rules apply to stand-alone dental.
January 05, 2012
DOL to AdvisorOne: Department ‘Has Not Signaled’ Extension of April 1 Fee Disclosure DeadlineWhile rumors were flying that Labors Employee Benefits Security Administration planned to push back the April 1 deadline for compliance with its fee disclosure regulations, a DOL spokesman told AdvisorOne on Thursday that the department had 'not signaled' that the deadline would be extended.
January 04, 2012
SEC Brings Up Charges on Life Partners HoldingsThe SEC alleges that Life Partners Holdings Inc., in conjunction with Dr. Donald T. Cassidy, purposefully underestimated the life expectancies of policyholders in what may be a punishing episode for the secondary market's larger reputation.